S. Morisson, P. Vassal, B. Rochas, J. Verborg, P. Guettet et al.,

, Médicaments administrables par voie sous-cutanée en soins palliatifs: revue de la littérature et recommandations. Médecine Palliative: Soins de SupportAccompagnement-Éthique, vol.11, pp.39-49, 2012.

A. Mattia and F. Coluzzi, What anesthesiologists should know about paracetamol (acetaminophen). Minerva anestesiologica, vol.75, pp.644-53, 2009.

M. Picon and L. Duwig, Administration des médicaments par voie sous-cutanée ; une alternative intéressante en gériatrie, Repères en Gériatrie, vol.13, issue.109, pp.143-149, 2011.

J. Masson, Etat des lieux de l'utilisation du paracétamol par voie sous-cutanée dans les USP en France. En cours de publication, 2016.

J. Jouquan, L 'évaluation des pratiques confrontée à l 'exigence de la preuve scientifique en médecine clinique. Médecine thérapeutique, vol.9, pp.93-100, 2003.

H. Morse, Ueber eine neue Darstellungsmethode der Acetylamidophenole

, Berichte der deutschen chemischen Gesellschaft, vol.11, issue.1, pp.232-235, 1878.

J. Bonnefont, J. Courade, A. Alloui, and A. Eschalier,

, Drugs, vol.63, pp.1-4, 2002.

R. Flower and J. Vane, Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol), Nature, vol.240, issue.5381, pp.410-411, 1972.

J. A. Mitchell, P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane, Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase, Proceedings of the National Academy of Sciences, vol.90, issue.24, pp.11693-11700, 1993.

F. Coluzzi and C. Mattia, Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants, Current pharmaceutical design, vol.11, issue.23, pp.2945-60, 2005.

J. Bonnefont, A. Alloui, E. Chapuy, E. Clottes, and A. Eschalier, Orally Administered Paracetamol Does Not Act Locally in the Rat Formalin TestEvidence for a Supraspinal, Serotonin-dependent Antinociceptive Mechanism, The Journal of the American Society of Anesthesiologists, vol.99, issue.4, pp.976-81, 2003.

A. Srikiatkhachorn, N. Tarasub, and P. Govitrapong, Acetaminophen-induced antinociception via central 5-HT 2A receptors, Neurochemistry international, vol.34, issue.6, pp.491-499, 1999.

A. Bertolini, A. Ferrari, A. Ottani, S. Guerzoni, R. Tacchi et al., Paracetamol: new vistas of an old drug, CNS drug reviews, vol.12, issue.3-4, pp.250-75, 2006.

. Paracétamol and . Vidal,

B. Anderson, J. Monteleone, and N. Holford, Variability of concentrations after rectal paracetamol. Paediatric anaesthesia, vol.8, p.274, 1997.

T. G. Hansen, K. O'brien, N. Morton, and S. Rasmussen, Plasma paracetamol concentrations and pharmacokinetics following rectal administration in neonates and young infants, Acta anaesthesiologica scandinavica, vol.43, issue.8, pp.855-864, 1999.

S. Cullen, D. Kenny, O. Ward, and K. Sabra, Paracetamol suppositories: a comparative study. Archives of disease in childhood, vol.64, pp.1504-1509, 1989.

G. Corcoran, J. Mitchell, Y. Vaishnav, and E. Horning, Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-pbenzoquinoneimine, Molecular Pharmacology, vol.18, issue.3, pp.536-578, 1980.

K. S. Albert, A. J. Sedman, and J. G. Wagner, Pharmacokinetics of orally administered acetaminophen in man, Journal of pharmacokinetics and biopharmaceutics, vol.2, issue.5, pp.381-93, 1974.

A. Mofredj, J. Cadranel, B. Darchy, J. Barbare, A. Cazier et al.,

, Annales de medecine interne, 1999.

S. P. Spielberg and G. B. Gordon, Glutathione synthetase-deficient lymphocytes and acetaminophen toxicity, Clinical Pharmacology & Therapeutics, vol.29, issue.1, pp.51-56, 1981.

, Évaluation et prise en charge thérapeutique de la douleur chez les personnes âgées ayant des troubles de la communication verbale, ANAES, 2000.

B. H. Rumack and H. Matthew, Acetaminophen poisoning and toxicity, Pediatrics, vol.55, issue.6, pp.871-877, 1975.

R. Miller, R. Roberts, and L. Fischer, Acetaminophen elimination kinetics in neonates, children, and adults, Clinical Pharmacology & Therapeutics, vol.19, issue.3, pp.284-94, 1976.

A. T. Chan, J. E. Manson, C. M. Albert, C. U. Chae, K. M. Rexrode et al., Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events, Circulation, vol.113, issue.12, pp.1578-87, 2006.

D. Vries, F. Setakis, E. , V. Staa, and T. P. , Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes, British journal of clinical pharmacology, vol.70, issue.3, pp.429-467, 2010.

L. F. Prescott, Paracetamol: past, present, and future, American journal of therapeutics, vol.7, issue.2, pp.143-151, 2000.

C. J. Nikles, M. Yelland, D. Mar, C. Wilkinson, and D. , The role of paracetamol in chronic pain: an evidence-based approach, American journal of therapeutics, vol.12, issue.1, pp.80-91, 2005.

W. H. Organization, Cancer pain relief: with a guide to opioid availability: World Health Organization, 1996.

M. Afssaps,

I. Krakowski and . Standards, Options et Recommandations 2002 pour les traitements antalgiques médicamenteux des douleurs cancéreuses par excès de nociception chez l'adulte, mise à jour (rapport abrégé), Bulletin du cancer, vol.89, issue.12, pp.1067-74, 2003.

A. Zeidan, J. Mazoit, M. A. Abdullah, H. Maaliki, T. Ghattas et al., Median effective dose (ED50) of paracetamol and morphine for postoperative pain: a study of interaction, British journal of anaesthesia, vol.112, issue.1, pp.118-141, 2014.

R. A. Medve, J. Wang, and R. Karim, Tramadol and acetaminophen tablets for dental pain, Anesthesia progress, vol.48, issue.3, p.79, 2001.

A. D. Masman, M. Van-dijk, D. Tibboel, F. P. Baar, and R. A. Mathôt, Medication use during end-of-life care in a palliative care centre, International journal of clinical pharmacy, vol.37, issue.5, pp.767-75, 2015.

P. Russell, Analgesia in terminal malignant disease, British medical journal, vol.1, issue.6177, p.1561, 1979.

F. Graham, Pousse seringue et sites d'injection sous-cutanés : une revue, European Journal of palliative care, vol.13, issue.4, pp.138-179, 2006.

V. Dardaine, M. Ferry, and T. Constans, La perfusion sous-cutanée ou hypodermoclyse: une technique de réhydratation utile en gériatrie, La Presse Médicale, vol.28, issue.40, pp.2246-50, 1999.

M. Lamandé, V. Dardaine-giraud, H. Ripault, D. Chavanne, and T. Constans, Utilisation de l'hypodermoclyse en gériatrie: étude prospective sur 6 mois. L'Année gérontologique, vol.18, pp.121-151, 2004.

J. Dutertre and T. Constans, L'hypodermoclyse: une technique oubliée?. La Revue de médecine interne, vol.12, pp.153-158, 1991.

C. Fonzo-christe, C. Vukasovic, A. F. Wasilewski-rasca, and P. Bonnabry, Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review, Palliat Med, vol.19, issue.3, pp.208-227, 2005.

G. Slesak, J. W. Schnürle, E. Kinzel, J. J. Dietz, and P. , Comparison of subcutaneous and intravenous rehydration in geriatric patients: a randomized trial, Journal of the American Geriatrics Society, vol.51, issue.2, pp.155-60, 2003.

R. J. Schen and . Singer-edelstein-m, Subcutaneous infusions in the elderly, Journal of the American Geriatrics Society, vol.29, issue.12, pp.583-588, 1981.

J. Lemeray, N. Kluger, and C. Girard, Effet secondaire de l'hypodermoclyse: une présentation clinique inhabituelle. Annales de dermatologie et de vénéréologie, 2012.

C. Lejus, M. Renaudin, S. Testa, J. Malinovsky, T. Vigier et al., Midazolam for premedication in children: nasal vs. rectal administration, European journal of anaesthesiology, vol.14, issue.03, pp.244-253, 1997.

C. Lejus, G. Renaud, and E. Legendre, Faut-il continuer à utiliser le paracétamol par voie rectale ? Communications scientifiques MAPAR, pp.217-240, 2001.

L. L. Christrup, D. Foster, L. D. Popper, T. Troen, and R. Upton, Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study, Clinical therapeutics, vol.30, issue.3, pp.469-81, 2008.

S. Grassin-delyle, A. Buenestado, E. Naline, C. Faisy, S. Blouquit-laye et al., Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids, Pharmacology & therapeutics, vol.134, issue.3, pp.366-79, 2012.

D. Boer, A. , D. Leede, L. Breimer, and D. , Drug absorption by sublingual and rectal routes, BJA: British Journal of Anaesthesia, vol.56, issue.1, pp.69-82, 1984.

M. A. Rodger and L. King, Drawing up and administering intramuscular injections: a review of the literature, Journal of Advanced Nursing, vol.31, issue.3, pp.574-82, 2000.

D. Sousa, R. Dang, A. Rataboli, and P. , Nicolau syndrome following intramuscular benzathine penicillin, Journal of postgraduate medicine, vol.54, issue.4, p.332, 2008.

R. Twycross, V. Pace, M. Mihalyo, and A. Wilcock, Journal of pain and symptom management, vol.46, pp.747-55, 2013.

G. G. Graham, K. F. Scott, and R. O. Day, Tolerability of paracetamol, Drug Safety, vol.28, issue.3, pp.227-267, 2005.

B. Bannwarth and F. Pehourcq,

, Drugs, vol.63, pp.5-13, 2003.

L. Tremblay-nguyen, S. Noublanche, J. Barre, H. Besselievre, M. Bore et al., Prise en charge des personnes âgées douloureuses. La Revue de gériatrie, vol.37, pp.173-83, 2012.

G. Pickering, . Douleur, and . Âgé, Les cahiers de l'année gérontologique, vol.6, pp.21-26, 2014.

, Agence Française de Sécurité Sanitaire des Produits de Santé. Prise en charge des douleurs de l'adulte modérées à intense

P. Rat, E. Jouve, G. Pickering, L. Donnarel, L. Nguyen et al., Validation of an acute pain-behavior scale for older persons with inability to communicate verbally: Algoplus®, European Journal of Pain, vol.15, issue.2, 2011.

O. Maison, B. De-la-gastine, L. Peter-derex, C. Berger, and S. Goutelle, Administration de lévétiracétam par voie sous-cutanée en gériatrie, Revue Neurologique, vol.171, issue.4, pp.398-407, 2015.
DOI : 10.1016/j.neurol.2015.01.567

J. M. López-saca, J. Vaquero, A. Larumbe, J. Urdíroz, and C. Centeno, Repeated use of subcutaneous levetiracetam in a palliative care patient, Journal of pain and symptom management, vol.45, issue.5, pp.7-8, 2013.

E. Bruera, M. A. Legris, N. Kuehn, and M. J. Miller, Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer, J Pain Symptom Manage, vol.5, issue.4, pp.218-238, 1990.

P. Walker, S. Watanabe, P. Lawlor, J. Hanson, J. Pereira et al., Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity, Ann Oncol, vol.8, issue.9, pp.915-921, 1997.

J. R. Thomas, R. C. Yocum, M. F. Haller, and J. Flament, The INFUSE-Morphine IIB study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneous morphine in healthy volunteers, J Pain Symptom Manage, vol.38, issue.5, pp.673-82, 2009.

F. Adams, L. Cruz, M. J. Deachman, and E. Zamora, Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain, J Pain Symptom Manage, vol.4, issue.1, pp.31-34, 1989.

H. J. Cools, A. M. Berkhout, D. Bock, and G. H. , Subcutaneous morphine infusion by syringe driver for terminally ill patients, Age Ageing, vol.25, issue.3, pp.206-214, 1996.

N. Champoux, D. Souich, P. Ravaoarinoro, M. Phaneuf, D. Latour et al., Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers, Br J Clin Pharmacol, vol.42, issue.3, pp.325-356, 1996.

J. Hardy, S. Quinn, B. Fazekas, J. Plummer, S. Eckermann et al., Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain, J Clin Oncol, vol.30, issue.29, pp.3611-3618, 2012.

A. Barbot, N. Venisse, F. Rayeh, S. Bouquet, B. Debaene et al., Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors, Intensive care medicine, vol.29, issue.9, pp.1528-1562, 2003.

J. Taillandier, G. Manigand, P. Fixy, and D. Dumont, Skin necrosis induced by subcutaneous gentamicin, Presse medicale, vol.13, issue.25, pp.1574-1579, 1983.

F. Bricaire, J. Castaing, J. Pocidalo, and J. Vilde, Pharmacokinetics and tolerance of ceftriaxone after subcutaneous administration, Pathologie-biologie, vol.36, issue.5, pp.702-707, 1988.

E. Forestier, S. Gros, D. Peynaud, M. Levast, D. Boisseau et al., Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea, Medecine et maladies infectieuses, vol.42, issue.9, pp.440-443, 2012.

L. Bartz, C. Klein, A. Seifert, I. Herget, C. Ostgathe et al., Subcutaneous administration of drugs in palliative care: results of a systematic observational study, Journal of pain and symptom management, vol.48, issue.4, pp.540-547, 2014.

G. Enzi, M. Gasparo, P. R. Biondetti, D. Fiore, M. Semisa et al., Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography, The American Journal of Clinical Nutrition, vol.44, issue.6, pp.739-785, 1986.

S. Lemieux, D. Prud'homme, A. Tremblay, C. Bouchard, and J. Despres, Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity, vol.20, pp.618-642, 1996.

A. , Modalités de prise en charge de l'adulte nécessitant des soins palliatifs. Recommandations pour la pratique clinique, 2012.

J. Bénézech, Souffrance de fin de vie : jusqu'où médicaliser ?, Ethique et Santé, vol.9, pp.55-64, 2013.

, Code de la santé publique. Art. 1110-5. Site legifrance.gouv.fr

S. Picard, Passer en voie sous-cutanée: un réel changement du projet palliative avant un simple changement de voie d'administration. Médecine Palliative: Soins de Support-Accompagnement-Éthique, vol.11, pp.1-2, 2012.

O. 'doherty, C. Hall, E. Schofield, L. Zeppetella, and G. , Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire, Palliative medicine, vol.15, issue.2, pp.149-54, 2001.

K. Sato, M. Miyashita, T. Morita, S. Tsuneto, and Y. Shima, End-of-Life Medical Treatments in the Last Two Weeks of Life in Palliative Care Units in Japan, A Nationwide Retrospective Cohort Survey, 2005.